Viloxazine Hydrochloride
CAS 3564-70-7 17 FDA-DMF suppliersSmall Molecule
Overview
Viloxazine Hydrochloride is a selective norepinephrine reuptake inhibitor used primarily in the treatment of attention deficit hyperactivity disorder (ADHD). It works by modulating the levels of certain neurotransmitters in the brain to improve attention, focus, and impulsivity.
API suppliers (3)
Suppliers of Viloxazine Hydrochloride backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.
- LEE PHARMA LTDIndia1 active DMF
- LEE PHARMA LTDIndia1 active DMF
- LEE PHARMA LTDIndia1 active DMF
Therapeutic areas
Attention Deficit Hyperactivity Disorder (ADHD)Norepinephrine Reuptake Inhibitor
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.